Dosing time-dependent effect of temocapril on the mortality of stroke-prone spontaneously hypertensive rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 1, 2006, Pages 176-181

  Nozawa, Masahiko ^a   Sugimoto, Koh Ichi ^a   Ohmori, Masami ^a   Ando, Hitoshi ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TEMOCAPRIL; TEMOCAPRILAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL RATE; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; AREA UNDER CURVE; BLOOD PRESSURE; BRAIN; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HYPERTENSION; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; SODIUM, DIETARY; SURVIVAL; THIAZEPINES; TIME FACTORS;

EID: 29244466813     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.092080     Document Type: Article

References (40)

1. Arakawa M, Ohmori M, Harada K, Araki N, Saitoh T, and Fujimura A (2005) Different accumulation of temocapril and enalapril during repeated dosing in elderly patients. Br J Clin Pharmacol 59:489-490.
2. Bader M (2002) Role of the local renin-angiotensin system in cardiac damage: a minireview focusing on transgenic animal models. J Mol Cell Cardiol 34:1455-1462.
3. Belanger PM, Bruguerolle B, and Labreque G (1999) Rhythms in pharmacokinetics: absorption, distribution, metabolism and excretion, in Physiology and Pharmacology of Biological Rhythms (Redfern PH and Lemmer B eds) pp 177-204, Springer, Berlin, Germany.
4. Blezer EL, Nicolay K, Bar D, Goldschmeding R, Jansen GH, Koomans HA, and Joles JA (1998) Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats. Stroke 29:1671-1678.
5. Campbell DJ, Kladis A, and Duncan AM (1994) Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23:439-449.
6. Cui Y, Sugimoto K, Kawai Y, Sudoh T, Gemba M, and Fujimura A (2004) Chronotoxicity of nedaplatin in rats. Chronobiol Int 21:601-611.
7. Debon R, Boselli E, Guyot R, Allaouchiche B, Lemmer B, and Chassard D (2004) Chronopharmacology of intrathecal sufentanil for labor analgesia: daily variations in duration of action. Anesthesiology 101:978-982.
8. European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21:1011-1053.
9. Fernandes-Alfonso MS, Kreutz R, Zeh K, Liu Y, Ganten D, and Paul M (1994) Differential regulation of vascular angiotensin I-converting enzyme in hypertension. Hypertension 24:280-286.
10. Filipski E, Lemaigre G, Liu XH, Mery-Mignard D, Mahjoubi M, and Levi F (2004) Circadian rhythm of irinotecan tolerability in mice. Chronobiol Int 21:613-630.
11. Graf M, Fischman AJ, Kastin AJ, and Moldow RL (1988) Circadian variation in response to CRF-41 and AVP. Am J Physiol 255:E265-E271.
12. Hanes DS, Nahar A, and Weir MR (2004) The tissue renin-angiotensin- aldosterone system in diabetes mellitus. Curr Hypertens Rep 6:98-105.
13. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hender T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, et al. (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 353:611-616.
14. Inada Y, Ojima M, Itoh K, Shino A, and Nishikawa K (1995) Effects of delapril on stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Drugs Exp Clin Res 21:41-49.
15. Ju H, Behm DJ, Nerurkar S, Eybye ME, Haimbach RE, Olzinski AR, Douglas SA, and Willette RN (2003) p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension. J Pharmacol Exp Ther 307:932-938.
16. Kasahara Y and Ashihara Y (1981) Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 27:1922-1925.
17. Kawashima S, Yamashita T, Miwa Y, Ozaki M, Namiki M, Hirase T, Inoue N, Hirata K, and Yokoyama M (2003) HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 34:157-163.
18. Kostis JB (1995) The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction. Am J Hypertens 8:909-914.
19. Labrecque G and Belanger PM (1991) Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol Ther 52:95-107.
20. Lemmer B, Witte T, Makabe T, Ganten D, and Mattes A (1994) Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats. J Cardiovasc Pharmacol 23:311-314.
21. Liebetrau M, Burggraf D, Wunderlich N, Jager G, Linz W, and Hamann GF (2005) ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats. Neurosci Lett 376:205-209.
22. Matsunaga N, Nakamura N, Yoneda N, Qin T, Terazono H, To H, Higuchi S, and Ohdo S (2004) Influence of feeding schedule on 24-h rhythm of hepatotoxicity induced by acetaminophen in mice. J Pharmacol Exp Ther 311:594-600.
23. Mizuno K, Shigetomi S, Matsui J, and Fukuchi S (1981) Effect of sodium intake on the brain and the aortic angiotensin-converting enzyme activity in spontaneously hypertensive rats. Jpn Heart J 22:839-845.
24. Ohmori M and Fujimura A (2005) ACE inhibitors and chronotherapy. Clin Exp Hypertens 27:179-185.
25. Okamoto K, Yamori Y, and Nagaoka A (1974) Establishment of the stroke-prone spontaneously hypertensive rats (SHR). Circ Res 34-35 (Suppl 1):I-143-I-153.
26. Oosting J, Struijker-Boudier HA, and Janssen BJ (1999) Timed inhibition of the renin-angiotensin system suppresses the rise in blood pressure upon awakening in spontaneously hypertensive rats. Am J Hypertens 12:1109-1118.
27. Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, and Pessina AC (1992) Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 52:378-383.
28. Shiga T, Sugimoto K, and Fujimura A (1999) Administration time-dependent effect of nitrendipine on the reduction of cardiac hypertrophy in spontaneously hypertensive rats. Am J Hypertens 12:1264-1267.
29. Shimamura T, Iwasaki T, Hayasaki-Kajiwara Y, Naya N, and Nakajima M (2002) Effects of losartan and benazepril on abnormal circadian blood pressure rhythm and target organ damage in SHRSP. Clin Exp Hypertens 24:187-205.
30. Shimokawa T, Moriuchi A, Hori T, Saito M, Naito Y, Kabasawa H, Nagae Y, Matsubara M, and Okuyama H (1988) Effect of dietary alpha-linolenate/linoleate balance on mean survival time, incidence of stroke and blood pressure of spontaneously hypertensive rats. Life Sci 43:2067-2075.
31. Shimonov M, Hayat H, Chaitchik S, Brener J, Schachter P, and Czerniak A (2005) Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver. Chemotherapy 51:111-115.
32. Shioya H, Shimojo M, and Kawahara Y (1991) Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay. J Chromatogr 568:309-314.
33. Sugimoto K, Ohmori M, Kawaguchi A, Tsuruoka S, and Fujimura A (2001) Dosing time-dependent effect of trandolapril on the prevention of cardiac hypertrophy in rats with aortic banding. Jpn J Pharmacol 87:86-89.
34. Sunaga K, Fujimura A, Shiga T, and Ebihara A (1995) Chronopharmacology of enalapril in hypertensive patients. Eur J Clin Pharmacol 48:441-445.
35. Suzuki H, Kawaratani T, Shioya H, Uji Y, and Saruta T (1993) Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS-622) in humans. Biopharm Drug Dispos 14:41-50.
36. Takai S, Sakanjo H, and Miyazaki M (2001) Beneficial effect of trandolapril on the lifespan of a severe hypertensive model. Hypertens Res 24:559-564.
37. Tsuruoka S, Nishiki K, Wakaumi M, Yamamoto H, Ando H, Ning W, and Fujimura A (2004) Chronopharmacology of oxacalcitriol in 5/6 nephrectomized rats. Life Sci 75:809-822.
38. Tsuruoka S, Wakaumi M, Sugimoto K, Saito T, and Fujimura A (2003) Chronotherapy of high-dose active vitamin D3 in haemodialysis patients with secondary hyperparathyroidism: a repeated dosing study. Br J Clin Pharmacol 55:531-537.
39. Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, and Lemmer B (1993) Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 54:177-186.
40. Yamori Y, Horie R, Handa H, Sato M, and Fukase M (1976) Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7:46-53.